SK11098A3 - Process for preparing solid dosage forms of very low-dose drugs - Google Patents

Process for preparing solid dosage forms of very low-dose drugs Download PDF

Info

Publication number
SK11098A3
SK11098A3 SK110-98A SK11098A SK11098A3 SK 11098 A3 SK11098 A3 SK 11098A3 SK 11098 A SK11098 A SK 11098A SK 11098 A3 SK11098 A3 SK 11098A3
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
carrier
composition according
drug
daily dose
Prior art date
Application number
SK110-98A
Other languages
English (en)
Slovak (sk)
Inventor
James A Napper
Karen T O'brien
Sultan J Manek
Rajinder Kumar
Julia M Loudon
Michael S G Clark
Neil Mortimer
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK11098A3 publication Critical patent/SK11098A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK110-98A 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs SK11098A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process
PCT/EP1996/003326 WO1997004750A2 (fr) 1995-07-29 1996-07-29 Procede de preparation de formes galeniques solides de medicaments en tres faibles doses

Publications (1)

Publication Number Publication Date
SK11098A3 true SK11098A3 (en) 1998-07-08

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
SK110-98A SK11098A3 (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs

Country Status (25)

Country Link
EP (1) EP0841902A2 (fr)
JP (1) JPH11510493A (fr)
KR (1) KR19990035972A (fr)
CN (1) CN1196677A (fr)
AP (1) AP858A (fr)
AR (1) AR004178A1 (fr)
AU (1) AU716961B2 (fr)
BG (1) BG102266A (fr)
BR (1) BR9609804A (fr)
CA (1) CA2228048A1 (fr)
CZ (1) CZ24798A3 (fr)
DZ (1) DZ2077A1 (fr)
EA (2) EA199901055A1 (fr)
HU (1) HUP9900521A3 (fr)
IL (1) IL122897A0 (fr)
MA (1) MA23953A1 (fr)
MX (1) MX9800809A (fr)
NO (1) NO980384L (fr)
NZ (1) NZ315632A (fr)
OA (1) OA10659A (fr)
PL (1) PL325242A1 (fr)
SK (1) SK11098A3 (fr)
TR (1) TR199800156T1 (fr)
UY (1) UY24297A1 (fr)
WO (1) WO1997004750A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
IL138192A0 (en) 1998-03-11 2001-11-25 Smithkline Beecham Plc Controlled release oral dosage forms
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
US7867990B2 (en) 2000-12-14 2011-01-11 Ortho-Mcneil Pharmaceutical, Inc. Steroid hormone products and methods for preparing them
WO2005097076A2 (fr) * 2004-04-09 2005-10-20 Smithkline Beecham Corporation Produits pharmaceutiques a faibles doses
WO2026018154A1 (fr) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Associations de sabcoméline et d'antagonistes muscariniques ne pénétrant pas dans le snc
WO2026018155A1 (fr) 2024-07-16 2026-01-22 Syremis Therapeutics Ltd. Combinaisons de sabcoméine avec des antagonistes muscariniques pénétrant dans le système nerveux non central à action prolongée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
DK0392803T3 (da) * 1989-04-13 2004-10-18 Beecham Group Plc Hidtil ukendte forbindelser
ZA939565B (en) * 1993-12-21 1994-08-11 Applied Analytical Ind Inc Method for preparing low dose pharmaceutical products.

Also Published As

Publication number Publication date
IL122897A0 (en) 1998-08-16
EA000740B1 (ru) 2000-02-28
JPH11510493A (ja) 1999-09-14
WO1997004750A3 (fr) 1997-03-27
BG102266A (en) 1998-10-30
AR004178A1 (es) 1998-11-04
CN1196677A (zh) 1998-10-21
PL325242A1 (en) 1998-07-06
DZ2077A1 (fr) 2002-07-22
BR9609804A (pt) 1999-07-06
MA23953A1 (fr) 1997-04-01
WO1997004750A2 (fr) 1997-02-13
HUP9900521A3 (en) 2001-04-28
MX9800809A (es) 1998-04-30
AP9801170A0 (en) 1998-01-31
NZ315632A (en) 1999-11-29
UY24297A1 (es) 1997-01-23
AU6738496A (en) 1997-02-26
KR19990035972A (ko) 1999-05-25
CZ24798A3 (cs) 1998-06-17
AU716961B2 (en) 2000-03-09
HUP9900521A2 (hu) 1999-06-28
OA10659A (en) 2002-09-18
TR199800156T1 (xx) 1998-04-21
EA199901055A1 (ru) 2000-06-26
EP0841902A2 (fr) 1998-05-20
NO980384L (no) 1998-03-26
NO980384D0 (no) 1998-01-28
AP858A (en) 2000-07-12
CA2228048A1 (fr) 1997-02-13
EA199800179A1 (ru) 1998-10-29

Similar Documents

Publication Publication Date Title
US4673564A (en) Sustained release pharmaceutical composition of solid medical material
AU767289B2 (en) Omeprazole formulation
JP3589977B2 (ja) 活性成分としてクロドロン酸塩および賦形剤としてケイ化微晶質セルロースを含む医薬製剤
AU623177B2 (en) Granular pharmaceutical formulations
CA1303504C (fr) Preparation pharmaceutique contenant de l'acrivastine
EP1341527B1 (fr) Preparation pharmaceutique comprenant un principe actif disperse sur une matrice
US6214386B1 (en) Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
JPH0122245B2 (fr)
US6855336B2 (en) Omeprazole formulation
US4832952A (en) Pharmaceutical composition containing a liquid lubricant
US5464612A (en) Solid preparation comprising ion exchanger and active agent
EP0862421B1 (fr) Compositions pharmaceutiques a liberation rapide
CA1184497A (fr) Produit pharmaceutique
JP2017122056A (ja) 医薬含有造粒物の製造方法
US20020150618A1 (en) Process for preparing solid dosage forms of very low-dose drugs
SK11098A3 (en) Process for preparing solid dosage forms of very low-dose drugs
MXPA98000809A (en) Procedure to prepare forms of solid doses of very low dose of farm
CA2275626C (fr) Preformulations homogenes, a forte concentration en steroides, servant a produire des preparations pharmaceutiques solides et semi-solides faiblement dosees
CZ287149B6 (en) Pharmaceutical preparation containing gemfibrozil
JP2000239185A (ja) 医薬組成物
JPH08325142A (ja) ヨウ化イソプロパミド含有製剤
AU751607B2 (en) Method of treatment of dementia
EP0557064B1 (fr) Composition à libération contrÔlée
CN109833306B (zh) 一种罗沙替丁醋酸酯药用盐缓释微丸及其制备方法和其应用
US5306507A (en) Process and composition containing pamabrom and pyrilamine maleate